Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.
Here are the most exciting drugs in the pipeline right now.
Monoclonal antibody for autoimmune and neurodegenerative disorders.
A new report from OptumRx reveals the top 4 drugs in development for the second quarter of 2019.
Major blockbuster drugs slated for launch in 2019 are expected to have a significant impact on treating certain cancers, diabetes, peanut allergies, and other conditions.
In the past week, the migraine prevention drug market has suddenly heated up, with 2 new approvals by FDA.